H.R. 6626: The Heathcare Innovation and Marketplace Technologies Act

12 December 2012 Personalized Medicine Bulletin Blog

On December 3, 2012, Representative Mike Honda of California introduced The Healthcare Innovation and Marketplace Technologies Act (HIMTA), to foster more innovation in the health care industry by removing barriers in wireless health.

Office of  Wireless Health 

The bill would establish an Office of Wireless Health at the Food and Drug Administration (FDA) to coordinate with other governmental agencies and private industry, and provide recommendations to the FDA Commissioner on how to develop and maintain a consistent, reasonable, and predictable regulatory framework on wireless health issues. The goal of the Office of Wireless Health, according to Representative Honda’s office, is not to expand the mandate or responsibilities of the FDA, but rather to seek to better clarify and simplify existing regulations while providing sorely needed expertise in this important field. 

The bill will also establish an mHealth developer support program at the Department of Health and Human Services to help mobile application developers build their devices in line with current privacy regulations. An array of support resources are envisioned, such as a national hotline, an educational website, and a yearly report that will help translate the wide array of privacy guidelines into common English.

Other goals of the bill include creating a marketplace for innovation by creating a low-interest small business loan program to clinics and physician offices for the purchasing of new health information technologies. It also would create a tax incentive program to allow medical providers to deduct costs related to non-electronic health record information technology. A grant program would also be established to assist medical care providers in retraining their employees into new positions that use health information technology.

Implications for Personalized Medicine

Personalized medicine is more than targeted therapeutics, it also involves direct patient involvement in monitoring and selecting therapies. Smart phones and other mobile devices will lead the way, offering a cost-effective truly mobile means to collect and monitor patient care. This bill, if enacted, should foster innovation in this growing trend in health care delivery and facilitate the coming electronic revolution in health data storage and management.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.

Related Services